Literature DB >> 27060714

Pancreatic cyst epithelial denudation: a natural phenomenon in the absence of treatment.

Victoria Gómez1, Shounak Majumder2, Thomas C Smyrk3, Mark D Topazian2, Suresh T Chari2, Ferga C Gleeson2, William S Harmsen4, Felicity T Enders4, Barham K Abu Dayyeh2, Prasad G Iyer2, Randall K Pearson2, Bret T Petersen2, Elizabeth Rajan2, Naoki Takahashi5, Santhi S Vege2, Kenneth K Wang2, Michael J Levy2.   

Abstract

BACKGROUND AND AIMS: The presence and significance of epithelial denudation among treatment-naïve pancreatic cystic lesions (PCLs) remain undetermined. The aims of this study were to determine the prevalence, extent, and predictors of epithelial denudation in treatment-naïve PCLs.
METHODS: Single-center retrospective study including patients who underwent EUS preceded by cross-sectional imaging and who subsequently underwent surgical resection of treatment-naïve PCLs. Surgically resected PCLs were reviewed by a pathologist in a fashion that allowed evaluation from evenly distributed regions of the cyst.
RESULTS: A total of 140 patients were identified (60% female, mean age 63 years). Eighty-five cysts (60.7%) were classified as intraductal papillary mucinous neoplasms (IPMNs), 33 (23.5%) as main duct IPMNs (m-IPMNs), 11 (7.9%) as serous cystadenomas (SCAs), and 11 (7.9%) were composed of other cyst subtypes. A greater extent of epithelial denudation was seen in mucinous cystic neoplasm (MCN) compared with IPMN and SCA (mean percentage of denuded epithelium 45.1%, 10.8%, and 22.4%, respectively [P < .0001]). An association existed between the extent of denuded epithelium and degree of cyst epithelial dysplasia for IPMN and MCN combined (mean percentage of denuded epithelium for low-, moderate-, and high-grade dysplasia being 23.3%, 4.5%, and 1.2%, respectively; P = .02). PCLs resected from the neck and/or body and/or tail of the pancreas were associated with a greater extent of mean percentage of denuded epithelium than PCLs resected from the head and/or uncinate of the pancreas (23.9% vs 13.4%; P = .035).
CONCLUSIONS: The presence and extent of cyst epithelial denudation of treatment-naïve PCLs vary with cyst histology and other factors. The observation of denudation after intracystic ablative therapy may not provide an adequate metric of successful intervention. Further studies are needed to validate these findings.
Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27060714     DOI: 10.1016/j.gie.2016.03.1502

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  3 in total

1.  Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.

Authors:  Shounak Majumder; William R Taylor; Tracy C Yab; Calise K Berger; Brian A Dukek; Xiaoming Cao; Patrick H Foote; Chung Wah Wu; Douglas W Mahoney; Harry R Aslanian; Carlos Fernández-Del Castillo; Leona A Doyle; James J Farrell; William E Fisher; Linda S Lee; Yvonne N Lee; Walter Park; Clifton Rodrigues; Bonnie Elyssa Gould Rothberg; Ronald R Salem; Diane M Simeone; Sumithra Urs; George Van Buren; Thomas C Smyrk; Hatim T Allawi; Graham P Lidgard; Massimo Raimondo; Suresh T Chari; Michael L Kendrick; John B Kisiel; Mark D Topazian; David A Ahlquist
Journal:  Am J Gastroenterol       Date:  2019-09       Impact factor: 10.864

2.  In vivo and ex vivo confocal endomicroscopy of pancreatic cystic lesions: A prospective study.

Authors:  Somashekar G Krishna; Rohan M Modi; Amrit K Kamboj; Benjamin J Swanson; Phil A Hart; Mary E Dillhoff; Andrei Manilchuk; Carl R Schmidt; Darwin L Conwell
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

3.  Improving the yield of EUS-guided histology.

Authors:  Luca Barresi; Matteo Tacelli; Ilaria Tarantino; Fabio Cipolletta; Antonino Granata; Mario Traina
Journal:  Endosc Ultrasound       Date:  2018 Sep-Oct       Impact factor: 5.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.